Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sodium-coupled neutral amino acid transporters (SNATs), primarily belonging to the SLC38 solute carrier family, are essential membrane proteins that mediate the uptake of small neutral amino acids such as glutamine, alanine, and serine [1, 4]. These transporters utilize the sodium electrochemical gradient to concentrate substrates within the cytoplasm, where they serve as critical precursors for protein synthesis, energy production, and the activation of the mTORC1 signaling pathway [6, 14]. In the context of oncology, SNATs (particularly SNAT1 and SNAT2) are frequently overexpressed to support the high metabolic demands of tumor cells, facilitating glutaminolysis and promoting rapid proliferation [2, 17]. Beyond cancer, SNATs play vital roles in neurotransmitter cycling between neurons and glia, as well as in hepatic gluconeogenesis and renal acid-base balance [2, 12]. Therapeutic development focuses on small-molecule inhibitors to starve cancer cells of vital nutrients, although achieving selectivity remains a challenge due to the widespread physiological expression of these transporters in the brain, liver, and muscle [16, 23].
Inhibition of sodium-dependent neutral amino acid uptake (primarily glutamine and alanine), which induces nutrient deprivation, suppresses the mTORC1 signaling pathway, and disrupts metabolic homeostasis in rapidly proliferating cells.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium-coupled neutral amino acid transporter (SNAT).